Analysis of renal impairment in children with Wilson's disease

Xiao-Hui Zhuang1, Ying Mo, Xiao-Yun Jiang

  • 1Department of Pediatrics, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.

Insights

Wilson's disease (hepatolenticular degeneration) often presents with varied renal impairment in children. Early kidney evaluation is crucial for diagnosis and monitoring, especially during D-penicillamine treatment.

Area of Science:

  • Pediatric Nephrology
  • Hepatology
  • Genetic Metabolic Disorders

Background:

  • Wilson's disease (hepatolenticular degeneration, HLD) can manifest with diverse renal complications, leading to potential misdiagnosis.
  • This study investigates the clinical characteristics of renal impairment in pediatric HLD patients.

Observation:

  • Of 85 pediatric HLD patients, 34 exhibited renal impairment.
  • Analysis of 25 patients revealed varied symptoms including edema, gross hematuria, acute renal failure, proteinuria, and hematuria.
  • Biochemical and urinalysis findings indicated tubular damage and glomerular involvement, with one case showing IgA nephropathy.

Findings:

  • Renal impairment in pediatric HLD is multifactorial, presenting with proteinuria, hematuria, and abnormal urine biomarkers.
  • Some patients showed signs of acute kidney injury and glomerular changes, highlighting the spectrum of renal involvement.
  • Corneal Kayser-Fleischer rings and decreased ceruloplasmin levels were consistent findings in affected children.

Implications:

  • HLD should be considered in the differential diagnosis of unexplained renal impairment in children.
  • Regular renal function and urinalysis monitoring are recommended for all HLD patients, particularly those undergoing D-penicillamine therapy.
  • Early detection and management of renal complications can improve outcomes for pediatric patients with Wilson's disease.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...